Invasive pulmonary fungal infections in patients with connective tissue disease: a retrospective study from northern China.
Invasive pulmonary fungal infection (IPFI) is a potentially fatal complication in patients with connective tissue disease (CTD). The current study aimed to uncover the clinical characteristics and risk factors of patients with IPFI-CTD. The files of 2186 CTD patients admitted to a single center in northern China between January 2011 and December 2013 were retrospectively reviewed. A total of 47 CTD patients with IPFI were enrolled into this study and assigned to the CTD-IPFI group, while 47 uninfected CTD patients were assigned to the control group. Clinical manifestations were recorded, and risk factors of IPFI were calculated by stepwise logistical regression analysis. Forty-seven (2.15%) CTD patients developed IPFI. Systemic lupus erythematosus patients were responsible for the highest proportion (36.17%) of cases with IPFI. Candida albicans (72.3%) accounted for the most common fungal species. CTD-IPFI patients had significantly elevated white blood cell count, erythrocyte sedimentation rate, C-reactive protein and fasting glucose values compared to controls (P<0.05). Cough, sputum and blood in phlegm were the most common symptoms. Risk factors of IPFI in CTD included maximum prednisone dose ≥30 mg/day within 3 months prior to infection, anti-microbial drug therapy, and interstitial pneumonia. CTD patients who have underlying interstitial pneumonia, prior prednisone or multiple antibiotics, were more likely to develop IPFI.
Department of Dermatology, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, Shandong, China.
H F
HF
Ge
Department of Dermatology, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, Shandong, China.
X Q
XQ
Liu
Laboratory Department, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, Shandong, China.
Y Q
YQ
Zhu
Department of Dermatology, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, Shandong, China.
H Q
HQ
Chen
Department of Dermatology, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, Shandong, China.
G Z
GZ
Chen
Rheumatology (Oxford). 2007 Mar;46(3):539-44
17043051
Infect Dis Clin North Am. 2006 Dec;20(4):849-75
17118293
Gene. 2012 Sep 10;506(1):184-7
22750799
Arthritis Rheum. 2005 Apr 15;53(2):155-65
15818648
J Rheumatol. 1975 Mar;2(1):61-72
1185736
Arthritis Res Ther. 2009;11(5):129
19960581
BMC Infect Dis. 2006 Feb 10;6:21
16472387
Arthritis Rheum. 1997 Sep;40(9):1725
9324032
Ann Rheum Dis. 2002 Jun;61(6):517-21
12006324
J Rheumatol. 2008 Mar;35(3):387-93
18260176
Infect Immun. 1993 Nov;61(11):4870-7
7691757
Lupus. 2013 Aug;22(9):892-8
23861029
Lupus. 2010 Sep;19(10):1204-9
20515999
JAMA. 1968 Jul 29;205(5):261-5
5694933
Pediatr Infect Dis J. 1988 Jul;7(7):499-504
3043365
J Rheumatol. 2007 Sep;34(9):1832-6
17659759
J Rheumatol. 2016 Sep;43(9):1650-6
27307524
Nihon Ishinkin Gakkai Zasshi. 2007;48(1):1-12
17287717
Ann Intern Med. 1984 Mar;100(3):345-51
6696356
Curr Opin Rheumatol. 2003 Sep;15(5):528-34
12960476
Arthritis Rheum. 1974 Jan-Feb;17(1):1-10
4810662
Dis Chest. 1960 Jul;38:51-5
13803423
Zhonghua Nei Ke Za Zhi. 2007 Jul;46(7):532-3
17959068
Curr Opin Rheumatol. 2004 Mar;16(2):109-13
14770094
Lupus. 2010 Oct;19(12):1419-24
20947551
Infect Dis Clin North Am. 2016 Mar;30(1):103-24
26739610
Arthritis Rheum. 1988 Mar;31(3):315-24
3358796
Zhonghua Jie He He Hu Xi Za Zhi. 2000 Jul;23(7):417-9
11778508
J Clin Invest. 1974 Jan;53(1):240-6
4808638
Lupus. 2009 Jun;18(7):661-6
19433470
N Engl J Med. 1975 Feb 13;292(7):344-7
1090839
Am J Med. 1972 Feb;52(2):148-59
4621694
Am J Respir Crit Care Med. 2005 Aug 1;172(3):268-79
15879420
Ann Rheum Dis. 2002 Jun;61(6):554-8
12006334
Ann Rheum Dis. 2005 Nov;64(11):1595-601
15843450
Z Rheumatol. 2009 Oct;68(8):658-64
19655156